NorthStar Asset Management (New Jersey)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25M Sell
2,446
-115
-4% -$117K 1.09% 24
2025
Q4
$2.75M Buy
2,561
+83
+3% +$79.4K 1.24% 25
2025
Q3
$1.89M Buy
2,478
+95
+4% +$70.7K 0.91% 26
2025
Q2
$1.86M Buy
2,383
+199
+9% +$155K 0.98% 26
2025
Q1
$1.8M Buy
2,184
+143
+7% +$119K 1.13% 25
2024
Q4
$1.58M Buy
2,041
+4
+0.2% +$3.31K 1% 25
2024
Q3
$1.8M Buy
2,037
+285
+16% +$256K 1.2% 24
2024
Q2
$1.59M Buy
1,752
+117
+7% +$93.6K 1.1% 25
2024
Q1
$1.27M Buy
1,635
+220
+16% +$157K 0.96% 26
2023
Q4
$825K Buy
+1,415
New +$826K 0.75% 29

Other funds holding LLY

NorthStar Asset Management (New Jersey)'s LLY Position: Q1 2026 in Review

NorthStar Asset Management (New Jersey) reduced its Eli Lilly (LLY) stake by 4.5% in Q1 2026, selling an estimated $117K and leaving 2,446 shares worth $2.25M. The position accounts for 1.09% of the portfolio, ranked #24.

NorthStar Asset Management (New Jersey) first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.75M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • NorthStar Asset Management (New Jersey) held 2,446 shares of Eli Lilly worth $2.25M as of Q1 2026.
  • NorthStar Asset Management (New Jersey) sold 115 Eli Lilly shares in Q1 2026, an estimated $117K.
  • Eli Lilly made up 1.09% of NorthStar Asset Management (New Jersey)'s portfolio in Q1 2026, its #24 holding.
  • NorthStar Asset Management (New Jersey) first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • NorthStar Asset Management (New Jersey)'s Eli Lilly position peaked at $2.75M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on NorthStar Asset Management (New Jersey)'s 13F filing for Q1 2026, filed 8 May 2026.